GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Classifica tra le azioni #3679
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Prezzo delle azioni
$27.10
Capitalizzazione di mercato
$4.59B
Variazione (1 giorno)
-1.59%
Variazione (1 anno)
-13.54%
Paese
IN
Scambia GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
L’azione GlaxoSmithKline Pharmaceuticals Limited (simbolo: GLAXO) ha subito un totale di 1 frazionamenti.
L’ultimo frazionamento è avvenuto il Sep 11, 2018.
Una quota di GLAXO acquistata prima di Sep 11, 2018 equivale oggi a 2 quote di GLAXO.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2018-09-11 2:1 x2 x2
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
4 x15
US
7 x432
US
0 -
US
7 x226
US
2 x10000
CH